You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東陽光藥(01558.HK)轉換H股股份獲聯交所批准上市
格隆匯 08-19 18:57

格隆匯 8 月 19日丨東陽光藥(01558.HK)發佈公告,公司已代參與股東就參與股東根據本次股份轉換所持內資股完成向中國結算北京分公司辦理註銷登記程序。2020年8月11日,持有2.262億股內資股的參與股東已自中國結算存置的公司內資股股東名冊中除名。

公司已向香港聯交所上市委員會申請批准2.262億股H股(轉換H股,即根據本次股份轉換將予轉換的內資股股份數目上限)上市及買賣。香港聯交所已於2020年8月18日授出上市批准。

根據目前時間表,預期轉換H股的股票將於2020年9月2日發出予中國結算香港及存入香香港結算管理的中央結算系統,而轉換H股將於2020年9月3日開始在聯交所上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account